全文获取类型
收费全文 | 38086篇 |
免费 | 3024篇 |
国内免费 | 2685篇 |
专业分类
耳鼻咽喉 | 466篇 |
儿科学 | 651篇 |
妇产科学 | 212篇 |
基础医学 | 4936篇 |
口腔科学 | 3950篇 |
临床医学 | 2631篇 |
内科学 | 3244篇 |
皮肤病学 | 119篇 |
神经病学 | 3909篇 |
特种医学 | 2255篇 |
外科学 | 12284篇 |
综合类 | 4030篇 |
现状与发展 | 8篇 |
预防医学 | 1024篇 |
眼科学 | 198篇 |
药学 | 1538篇 |
14篇 | |
中国医学 | 847篇 |
肿瘤学 | 1479篇 |
出版年
2024年 | 33篇 |
2023年 | 373篇 |
2022年 | 666篇 |
2021年 | 1066篇 |
2020年 | 938篇 |
2019年 | 900篇 |
2018年 | 1091篇 |
2017年 | 1130篇 |
2016年 | 1398篇 |
2015年 | 1346篇 |
2014年 | 2381篇 |
2013年 | 2710篇 |
2012年 | 2122篇 |
2011年 | 2315篇 |
2010年 | 2056篇 |
2009年 | 2028篇 |
2008年 | 1993篇 |
2007年 | 2006篇 |
2006年 | 1956篇 |
2005年 | 1932篇 |
2004年 | 1626篇 |
2003年 | 1408篇 |
2002年 | 1088篇 |
2001年 | 980篇 |
2000年 | 954篇 |
1999年 | 808篇 |
1998年 | 682篇 |
1997年 | 696篇 |
1996年 | 531篇 |
1995年 | 515篇 |
1994年 | 437篇 |
1993年 | 383篇 |
1992年 | 355篇 |
1991年 | 322篇 |
1990年 | 276篇 |
1989年 | 240篇 |
1988年 | 206篇 |
1987年 | 200篇 |
1986年 | 200篇 |
1985年 | 210篇 |
1984年 | 175篇 |
1983年 | 96篇 |
1982年 | 142篇 |
1981年 | 127篇 |
1980年 | 120篇 |
1979年 | 118篇 |
1978年 | 96篇 |
1977年 | 89篇 |
1976年 | 67篇 |
1973年 | 39篇 |
排序方式: 共有10000条查询结果,搜索用时 390 毫秒
71.
Teriparatide vs. calcitonin in the treatment of Asian postmenopausal women with established osteoporosis 总被引:4,自引:0,他引:4
J. S. Hwang S. T. Tu T. S. Yang J. F. Chen C. J. Wang K. S. Tsai 《Osteoporosis international》2006,17(3):373-378
This study compared the clinical efficacy, safety, and tolerability of daily subcutaneous injections of teriparatide and salmon
calcitonin in the treatment of postmenopausal women with established osteoporosis in Taiwan. This 6-month, multicenter, randomized,
controlled study enrolled 63 women with established osteoporosis. They were randomized to receive either teriparatide 20 μg
or calcitonin 100 IU daily in an open-label fashion. Lumber spine, femoral neck, total hip bone mineral density (BMD), and
biochemical markers of bone turnover were measured, and adverse events and tolerability were recorded. The results at 6 months
showed that patients using teriparatide had larger mean increases in spinal BMD than those who used calcitonin (4.5% vs. 0.1%),
but the BMD changes in these two groups at the femoral neck and the total hip were not significant. There were also larger
mean increases in bone markers in the teriparatide group than in the calcitonin group (bone specific alkaline phosphatase
142% vs. 37%; osteocalcin 154% vs. 23%). We conclude that teriparatide has more positive effects on bone formation than salmon
calcitonin, as shown by the larger increments of lumbar spine BMD and bone formation markers, and caused only mild adverse
events and no significant change in liver, kidney or hematological parameters. Compared with the published global results,
teriparatide seems to be equally effective and safe to use in this Asian population. 相似文献
72.
目的 探讨多药耐药基因(mdrl)转染骨髓造血细胞移植后,其在体内分布和安全性.方法 骨髓造血细胞转染mdrl基因后移植入BALB/C鼠,免疫组织化学和RT.PCR观察mdrl基因在骨髓、外周血及重要脏器的表达;监测外周血白细胞变化及重要脏器病检分析其安全性.结果 P-糖蛋白(P-gP)在骨髓表达率随时间降低,各时间组差异无统计学意义(x2=3.74,P>0.05),在外周血表达第2月最高,为(9.95±1.84)%,各时间组差异无统计学意义(x2=2.31,P>0.05),在重要脏器无表达;移植未转染组与移植转染组外周血白细胞计数至移植60 d后,两者差异有统计学意义(t=6.173,P<0.05),病检除肝和肾有炎性渗出和水肿病变外,其余无异常.结论 mdrl基因在骨髓和外周血有持续较高表达,在重要脏器无表达;mdrl基因转染对造血恢复及重要脏器无明显影响. 相似文献
73.
目的:评价数字曲面体层X片在测量非负荷期种植体周围牙槽骨吸收的应用情况。方法:观测、分析对比26例患者50枚Camlog系统种植体临床应用非负荷期间数字化曲面体层X片和X线牙片上种植体周围牙槽骨吸收的情况。结果:50枚Camlog种植体植入后10 d,两种X片骨吸收测量结果分别为0.65 mm、0.81 mm,两者之间无明显差异;第4个月(或6月\下颌)分别为0.12 mm、0.19 mm,两者之间无明显差异。结论:本研究显示数字化曲面体层X片在测量非负荷期种植体周围牙槽骨吸收的应用中有操作简单、重复性好、精确度高、变形可补偿等优点,有实际应用价值,值得推广。 相似文献
74.
Fengxiu Ouyang Binyan Wang Lester M. Arguelles Xiping Xu Jianhua Yang Zhiping Li Liuliu Wang Xue Liu Genfu Tang Houxun Xing Craig Langman Xiaobin Wang 《Archives of osteoporosis》2007,2(1-2):29-43
Summary We prospectively examined bone growth patterns in 894 children aged 6–17 years at the baseline visit, with a 6-year follow-up.
Results show bone “tracking” over a six-year interval and sexual dimorphism of bone attained levels and timing of peak bone
growth. Our findings underscore childhood and adolescence as critical periods for building bone and developing gender differences.
Introduction Bone growth patterns were prospectively examined in 894 Chinese children (496 males), aged 6–17 yrs, from a population-based
twin cohort. Whole-body bone area (BA), bone mineral content (BMC), and bone mineral density (BMD) were measured by DEXA at
baseline and a 6-yr follow-up.
Methods Graphic smoothing plots and generalized estimating equations were used to model bone attained levels, growth, and “tracking”.
Results Attained levels of BMC and BA increased curvilinearly with age. Male attained levels were higher than females after age ∼15 yr,
but BMD was lower between 13–17 yrs (Tanner stage I to IV). In both genders, peak BMC and BMD growth lagged ∼2 yrs behind
peak BA growth, which lagged 2 yrs behind peak height growth. Peak bone growth occurred 1–3 yrs later in males. Over the 6-yr
follow-up, all bone measurements “tracked”, but “shifting” across ranks also occurred, and baseline tertile ranking influenced
bone growth. Females with early menarche had higher attained levels than females with late menarche at age 12–13 yrs.
Conclusion Our findings confirm and expand previous studies on peak bone growth conducted in Caucasian cohorts, particularly sexually
dimorphic and maturational effects. The significant “tracking” of bone measurements in this 6-yr follow-up study underscores
the importance that osteoporosis prevention should begin in childhood and adolescence.
Fengxiu Ouyang and Binyan Wang contributed equally to this article.
Source(s) of support: This study is supported in part by grant R01 HD049059, R01 HL0864619 and R01 AR045651 from the National
Institute of Health and by the Food Allergy Project. 相似文献
75.
同种异体骨支撑架微创治疗股骨头坏死的临床研究 总被引:1,自引:0,他引:1
目的应用改良髓芯减压术结合同种异体骨支撑架加自体骨和脱钙骨基质(decalcified bone matrix,DBM)治疗早期股骨头坏死,探索早期股骨头坏死的微创治疗方法。方法2004年1月~2005年4月,23例24个髋关节采用经大转子下通过股骨颈钻隧道至股骨头骨坏死区,将装有自体松质骨和DBM的同种异体骨支撑架经隧道拧入骨坏死区直至软骨下骨约5mm处,隧道远端用自体髂骨填塞。观察手术前后Harris评分变化、x线影像学表现及是否需进一步治疗。结果本组所有患者均获得随访,平均随访19(12—27)个月,以最后一次随访资料作为最终评价依据。Harris评分,术前优良率为43.5%(10/23)。术后优良率为91.3%(21/23)。22侧髋关节影像学表现保持稳定,无明显并发症发生。结论同种异体骨支撑架植入结合自体松质骨和DBM治疗成人股骨头坏死,增加了股骨头负重区软骨下骨的机械支撑,成骨作用强,有利于股骨头坏死的修复与重建,同时,不破坏患者股骨头本身的血液供应,创伤小,操作简单,值得临床推广使用。 相似文献
76.
目的应用重组人骨形态发生蛋白4基因腺相关病毒载体(AAV-hBMP4)转染兔骨髓基质干细胞(BMSCs),观察其对BMSCs生物学行为的影响,从而为骨组织工程寻找理想的病毒载体及种子细胞。方法全骨髓法培养兔BMSCs,按感染复数(MOI)值不同设定为四组,分别转染兔BMSCs,观察病毒量对细胞形态的影响。选取影响最小的MOI值,进行后续实验。转染兔BMSCs,MTT法描记细胞生长曲线,观察AAV对细胞增殖活性的影响。以重组增强型绿色荧光蛋白基因的腺相关病毒载体(AAV-EGFP)为参照,行流式细胞仪检测,计算转染效率。AAV-hBMP4与对照病毒AAV-EGFP分别转染细胞,观察细胞形态,行碱性磷酸酶(ALP)染色、Von Kossa染色及ALP含量测定,观察成骨活性。兔肌袋实验观察异位成骨情况。结果MOI值为5×10~4 vg/cell时,AAV对细胞形态影响最小,以此值进行后续实验。AAV转染后,细胞增殖活性良好,转染效率为55%~65%。AAV-hBMP4转染后,细胞形态呈现典型的成骨改变,ALP染色及Von Kossa染色均出现成骨的特征性改变,而AAV-EGFP组无上述改变。细胞上清ALP含量测定显示,实验组ALP含量显著增高,与对照组比较差异有统计学意义(t=218.65,P<0.01)。兔肌袋实验术后4周组织学检测可见大量钙盐沉积,矿化结节形成。结论AAV-hBMP4转染效率高,对BMSCs的增殖活性影响小,AAV-hBMP4转染的BMSCs可望成为组织工程化骨的理想种子细胞。 相似文献
77.
G. Burastero N. Sessarego G. Grappiolo C. Castellazzo S. Castello A. Pitto G. Cittadini M. Podesta G. Bovio M. Peresi E. Fulcheri F. Frassoni L. Spotorno 《Journal of orthopaedics and traumatology》2007,8(1):49-54
Mesenchymal stem cells (MSC), easily culture-expanded from bone marrow, can significantly enhance bone defect healing. Several
proteins, such as the bone morphogenetic proteins (BMPs) and in particular BMP-7, are involved in bone formation in vitro
and in vivo. In this preclinical study, we evaluated if the association of human MSC (hMSC) with BMP-7 had synergic action
on bone healing. Rat femoral defects (n=12) were treated with: autoclaved bone and mononucleated cells (MNC) as control group
G1; bone and hMSC, group G2; bone with BMP-7, group G3; bone and hMSC plus BMP-7, group G4. Defect regeneration was evaluated
with plain radiographs after 2, 4, 8 and 12 weeks and with histological analysis. We observed organized trabeculae bridging
between the osteotomic ends of the host bone in rats treated with the association of hMSC and rhBMP-7. These trabeculae, formed
by a core of devitalized tissue surrounded by osteoblasts, osteocytes and osteoclasts, were continuous with a cortical-like
structure of bony tissue. Such new bone formation of the group treated with the association of hMSC and rhBMP-7 (G4) was clearly
superior compared to rats treated with rhBMP-7 (G2) or hMSC (G3) alone, as shown by radiographic analysis and histological
study. The present study suggests that the association of hMSC and BMP-7 is more effective than hMSC or BMP-7 alone in the
healing of femoral defects in rats. Further studies with larger samples are required to confirm these results and to evaluate
the best dosage. 相似文献
78.
周围神经端侧动脉套接后神经再生的研究 总被引:6,自引:2,他引:4
目的研究周围神经端侧动脉套接后神经再生的可能性及其特点. 方法取SD大鼠75只,在股骨中下段切断腓神经,将近断端逆转90度包埋于肌肉中.随机分为5组.A组:将截取的左颈总动脉套接于右侧正常胫神经侧方与腓总神经远端2 mm距离之间,缝合部胫神经外膜不予切除;B组:在胫神经套接部外膜开窗1.0 mm;C组:腓总神经切断14天后再予动脉套接,余同B组;D组:同B组,且于动脉套接部注入神经生长因子(neural growth factor, NGF)1 ml;E组:将腓总神经远端以端侧缝合形式直接缝合于胫神经的一侧,外膜开窗1.0 mm.术后4、8和12周分别行组织学、电镜和神经纤维计数等检查. 结果 4周时C、D及E组周边区域有神经纤维轴突和髓鞘再生,A组则无神经纤维生长; 8周时C、D及E组再生神经纤维较B组多,E组神经纤维较C、D组多,差异有统计学意义(P<0.05); 12周时C、D及E组神经纤维多于B组,差异有统计学意义(P<0.05);C组及D组有较丰富的神经再生,与神经端侧直接吻合的E组差异无统计学意义(P>0.05). 结论神经端侧2 mm距离动脉套接可作为修复周围神经损伤的一种可行方法. 相似文献
79.
Saskia L.M.A. Beeres MD Katja Zeppenfeld MD Jeroen J. Bax MD Petra Dibbets-Schneider Marcel P.M. Stokkel MD Willem E. Fibbe MD Ernst E. van der Wall MD Douwe E. Atsma MD Martin J. Schalij MD 《Heart rhythm》2007,4(3):257-265
BACKGROUND: Bone marrow cell injection has been introduced to treat patients with ischemic heart disease. However, focal application of bone marrow cells may generate an arrhythmogenic substrate. OBJECTIVES: To assess the electrophysiological and arrhythmogenic effects of intramyocardial bone marrow cell injection in patients with chronic myocardial ischemia. METHODS: Bone marrow was aspirated in 20 patients (65+/-11 years, 19 male) with drug-refractory angina and myocardial ischemia. Electroanatomical mapping (NOGA, Biosense-Webster, Waterloo, Belgium) was performed during mononuclear cell isolation. Areas for cell injection were selected based on the localization of ischemia on SPECT. These areas were mapped in detail to evaluate local bipolar electrogram duration, amplitude and fragmentation. Mononuclear cells were injected in the ischemic area with the NOGA system. SPECT and electroanatomical mapping were repeated at 3 months. Holter monitoring was repeated at 3 and 6 months. RESULTS: SPECT revealed a decrease in the number of segments with ischemia (3.5+/-2.5 vs. 1.1+/-1.0 at 3 months; P<0.01) and an increased left ventricular ejection fraction (44+/-13% vs. 49+/-17% at 3 months; P=0.02). The number of ventricular premature beats remained unchanged (10+/-24x10(2)/24h vs. 8+/-23x10(2)/24h at 3 months (P=NS) and 12+/-30x10(2)/24h at 6 months (P=NS)). At 3 months follow-up, bone marrow cell injection did not prolong electrogram duration (15.9+/-4.6 ms vs. 15.6+/-4.0 ms; P=NS), decrease electrogram amplitude (3.8+/-1.5 mV vs. 3.8+/-1.5 mV; P=NS), or increase fragmentation (2.0+/-0.5 vs. 1.9+/-0.4; P=NS). CONCLUSION: Intramyocardial bone marrow cell injection does not increase the incidence of ventricular arrhythmias and does not alter the electrophysiological properties of the injected myocardium. 相似文献
80.
目的探讨骨胶原含量在绝经后骨质疏松症的发生、发展及在骨质疏松性骨折中的作用。方法取7个月龄未交配雌性SD大鼠60只,随机分为四组,A组:对照组(sham组);B组:切除卵巢组;C组:切除卵巢+雌激素治疗组;D组:切除卵巢+降钙素治疗组。除A组外,其他三组通过切除双侧卵巢法12周后制成骨质疏松模型,24周后分别行k的力学特性、右侧股骨三点弯曲试验、羟脯氨酸含量、k骨密度(BMD)测定,Masson三色染色法显示骨胶原形态。结果A、C、D组与B组在k羟脯氨酸含量、BMD、k压缩力学参数值、右侧股骨生物力学参数值、骨胶原染色含量及形态方面差异均有统计学意义(P〈0.05),而A、C、D组之间差异无统计学意义(P〉0.05)。统计学分析显示羟脯氨酸含量与BMD及骨生物力学参数值呈直线相关性。结论骨质疏松的发生与骨胶原含量下降有关。骨胶原含量的下降与BMD降低及骨生物力学改变呈相关性。应用雌激素和降钙素治疗去势后骨质疏松大鼠,不仅可以提高其BMD含量和骨生物力学性能,而且还可以提高骨胶原的含量。 相似文献